Major positives
Enron Group participated in the compilation
Group standard for "Quality Requirements for Medicinal and Food Homologous Foods"
And officially released for implementation
Recently, the China Association for the Promotion of International Economic and Technical Cooperation reviewed and issued the "Quality Requirements for Medicinal and Food Homologous Foods", Enron Group participated in the drafting and preparation of the document, and was awarded the "Quality Requirements for Medicinal and Food Homologous Foods" group standard participating unit.
The standard stipulates the specification requirements for terms and definitions, classification, requirements, test methods, inspection rules, labels, packaging, etc. of medicinal and food homologous foods [including: beverages (including solid drinks, fruit and vegetable juice drinks, etc.), candies (including tablet candy), substitute tea, convenience foods, etc.), and is applicable to the production and inspection of medicinal and food homologous foods.
The birth of the group standard "Quality Requirements for Medicinal and Food Homologous Foods" can further standardize industry rules and regulations, promote industry development, and promote technological progress.
Enron Group's participation in the compilation of the group standard "Quality Requirements for Medicinal and Food Homologous Foods" is a high recognition of Enron Group's position in the food and health food industry by the China Council for the Promotion of International Economic and Technical Cooperation, and also reflects the importance of Enron Group as an industry benchmark.
Scientific research integrates ingenuity to lead the development of the industry
Over the years, Enron Group has always adhered to independent innovation and development, deeply cultivated the cutting-edge scientific and technological fields of nanotechnology and plant stem cell technology, and has great core competitiveness in the microscopic field of nanotechnology and plant stem cell technology, with hundreds of national patents.
Adhering to the concept of "medicine and food from the same source", Enron Zhonghe brand food and health food series products use advanced nanotechnology to break macromolecules into small molecule peptides, which greatly improves the absorption efficiency.
Enron brand food, health food
The introduction of Changbaishan special fresh wild ginseng, carry out stem cell technology research of Changbaishan special and other fresh wild ginseng, up to now, has obtained nearly 30 national invention patents. The industry standards that are being applied for have passed the review and formal approval of the Ministry of Agriculture.
Technology benefits society and achieves a safe life. Enron Group will not forget its original intention, focus on the research of nanotechnology and plant stem cell technology, keep up with the pace of the times, deepen the field of health, continuously promote industry innovation and breakthroughs, and contribute to the development of national health and medicine and food homologous industries.